Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
NCT Number:
NCT02205762
Phase:
II/III
Protocol Type:
Treatment
Age Group:
Children
Disease Sites:
Other Hematopoietic
Study Objectives:
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Study Documents
(MUSC NetID required for document access)